Omicron variant delays COVID-19 IP waiver debate

The World Trade Organization (WTO) has postponed its ministerial conference indefinitely, potentially ending the opportunity for countries to agree an IP waiver for COVID-19 vaccines this year.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotechnology

Activists urge Biden to champion temporary COVID-19 IP waiver

23 November 2021 Medical and human rights groups have called on US President Joe Biden to step up his personal engagement and help put in place a temporary waiver of IP rights for COVID-19 vaccines.

Big Pharma

Australia backs COVID-19 vaccine waiver

9 September 2021 Australia will waive IP protections for COVID-19 vaccines to enable more cost-effective copycat versions to be manufactured in developing countries, in the wake of mounting pressure from human rights groups and governments worldwide.

Americas

COVID-19 IP waiver faces uncertain future

31 March 2022 The future of the IP waiver related to the COVID-19 vaccine looks uncertain after the US Trade Representative confirmed no agreements had yet been reached between US, the EU, India and South Africa.

More on this story

Biotechnology

Activists urge Biden to champion temporary COVID-19 IP waiver

23 November 2021 Medical and human rights groups have called on US President Joe Biden to step up his personal engagement and help put in place a temporary waiver of IP rights for COVID-19 vaccines.

Big Pharma

Australia backs COVID-19 vaccine waiver

Americas

COVID-19 IP waiver faces uncertain future

More on this story

Biotechnology

Activists urge Biden to champion temporary COVID-19 IP waiver

23 November 2021 Medical and human rights groups have called on US President Joe Biden to step up his personal engagement and help put in place a temporary waiver of IP rights for COVID-19 vaccines.

Big Pharma

Australia backs COVID-19 vaccine waiver

Americas

COVID-19 IP waiver faces uncertain future